We hypothesized that (1) insulin-deficient type 1 diabetic mice will have greater propensity for AF and (2) insulin treatment will rescue alterations in glucose transport in the atria of insulin-deficient type 1 diabetic mice, and thereby reduce AF vulnerability. This evidence concerns the gene INS and atrial fibrillation.